FDA’s sunscreen decision proves the agency is done burning patients’ wallets

The FDA's decision to broaden the range of approved sunscreens signals a significant shift in consumer protection and market dynamics. This move promises to boost competition, offering consumers more options and potentially lower prices. It's a win for public health, as better choices can lead to greater adherence to sun protection, ultimately reducing the risk of skin cancer and other sun-related skin damage. This marks a crucial step for the FDA, showing a commitment to not just regulating but actively supporting consumer welfare.